Concord Biotech IPO Details | GMP, Date, Price, Review

Concord Biotech IPO

Table of Contents

Concord Biotech IPO Details ( Concord Biotech Limited IPO Review )

(04 Aug 2023 – 08 Aug 2023)

Concord Biotech Limited, founded in 1984, is an Indian biopharmaceutical company with a strong focus on research and development. Specializing in fermentation-based Active Pharmaceutical Ingredients (APIs) within the immunosuppressants and oncology segments, the company has earned a prominent position among global developers and manufacturers based on market share by volume in 2022.

With a widespread presence worldwide, Concord Biotech supplies its products to more than 70 countries, including major markets like the USA, India, Europe, and Japan.

The company’s expertise lies in manufacturing APIs through fermentation and semi-synthetic processes, as well as producing finished formulations. Starting with a single product, Concord Biotech has expanded its offerings to become a comprehensive solution provider.

Their product portfolio covers therapeutic segments such as Immunosuppressants, Anti-bacterial, Oncology, Antifungals, and more, drawing interest from customers across the globe. Additionally, Concord boasts a promising pipeline of products currently under development.

Concord Biotech IPO Listed On ₹900.05 & Listing Gain 21.46%

Concord Biotech IPO Listing Day Trading Information:

Concord Biotech IPOData
BSE Symbol543960
Listing Date18 August 2023
Issue Price₹705 to ₹741
Listed Price₹900.05
Listing Gain21.46%

Concord Biotech Limited Company Product

  • Formulations
  • APIs

Concord Biotech Limited IPO Competitive Strength

  • Established presence across the complex fermentation value chain
  • Global leadership in immunosuppressant APIs along with a wide spectrum of complex fermentation-based APIs across multiple therapeutic areas
  • Scaled manufacturing facilities with a consistent regulatory compliance track record and supported by strong R&D capabilities
  • Diversified global customer base with long-standing relationships with key customers
  • Experienced Promoters, management team supported by marquee investors
  • Financial track record of rapid growth and consistent profitability with healthy cash flows and strong shareholder returns

Concord Biotech IPO Financials Performance ( Results )

Concord Biotech Limited Financial Information (Restated Consolidated)

All Amount in ₹ Crores

Period EndedTotal AssetsTotal RevenuePATEPS
Net WorthReservesBorrowing

Objective of IPO Issue

  • Achieve the benefits of listing the Equity Shares on the Stock Exchanges and
  • Carry out the Offer for Sale of up to 20,925,652 Equity Shares by the Selling Shareholder.

Concord Biotech IPO Basic Details

IPO DateAug 4, 2023 to Aug 8, 2023
Listing DateFriday, August 18, 2023
Face Value₹1 per share
Price₹705 to ₹741 per share
Lot Size20 Shares
Issue Size20,925,652 shares
(aggregating up to ₹1,551.00 Cr)
Offer for Sale20,925,652 shares
(aggregating up to ₹1,551.00 Cr)
Issue TypeBook Built Issue IPO
Employee DiscountRs 70 per share
Listing AtNSE, BSE
Share holding pre issue104,616,204
Share holding post issue104,616,204
Company PromotersSudhir Vaid And Ankur Vaid

Concord Biotech IPO Anchor Investors Basic Details

Bid DateAug 3, 2023
Shares Offered6,274,695
Anchor Portion Size (In Cr.)₹464.95
Anchor lock-in period ends in 30 days for 50% shares.Sep 26, 2023
Remaining shares anchor lock-in period ends in 90 days.Dec 26, 2023
Concord Biotech IPO Anchor Investors list DetailsDownload

Concord IPO Reservation

QIB Shares Offered50% of the Net Issue
NII (HNI) Shares Offered15% of the Net Issue
Retail Shares Offered35% of the Net Issue

Concord IPO Timetable

Concord IPO will open on August 4, 2023 and close on August 8, 2023. You can join Concord Biotech IPO at 10.00 A.M. to 5.00 p.m. Upto which mandate can be applied.

Opening Date4 August 2023 (Friday)
Closing Date8 August 2023 (Tuesday)
Basis of Allotment11 August 2023 (Friday)
Initiation of Refunds14 August 2023 (Monday)
Credit of Shares to Demat17 August 2023 (Thursday)
Listing Date18 August 2023 (Friday)
Deadline for UPI mandate confirmation5 PM on 8 August 2023

Concord Biotech IPO Lot Size

For retail investors in Concord Biotech IPO, 20 shares will come in 1 lot or the minimum investment will be ₹000,000. Retail-individual investors can apply for up to 1 lots or the maximum investment will be ₹000,000.

Retail (Min)120₹14,820
Retail (Max)13260₹192,660
S-HNI (Min)14280₹207,480
S-HNI (Max)671,340₹992,940
B-HNI (Min)681,360₹1,007,760

Concord Biotech IPO Promoter Holding

The company’s promoters include Sudhir Vaid And Ankur Vaid.

Pre Issue Share Holding44.08%
Post Issue Share Holding44.08%

Concord Biotech Ltd IPO Key Performance Indicator ( Valuation )

In the table given below, all the figures have been told according to the latest financial year.

Market Cap (₹ Cr.)7752.06
Earning Per Share (EPS)₹22.95 per Equity Share
Net Asset Value (NAV)₹123.31 per Equity Share
P/E Ratio (P/E) (x)32.29
Return on Net Worth (RoNW) (%)20
Return on equity (ROE) (%)20.06
Return on Capital Employed (ROCE) (%)24.27
Debt/Equity Ratio0.02

Concord Biotech Ltd Peer Comparison

P/E Ratio has been computed based on the closing market price of equity shares on NSE on July 25, 2023, divided by the Diluted EPS.

Company NameConsolidated/
Concord Biotech
Peer Group
Divi’s Laboratories
Suven Pharmaceuticals
Laurus Labs LimitedConsolidated214.6423.7019.6875.16
Shilpa Medicare LimitedConsolidated1-3.74NANA204.41

Concord Biotech IPO GMP Live Update, Kostak Rate day by day

DateGMPKostakSubject to
16 August 2023₹122
15 August 2023₹122
14 August 2023₹122
13 August 2023₹122
12 August 2023₹122
11 August 2023₹122
10 August 2023₹122
9 August 2023₹122
8 August 2023₹122
7 August 2023₹155
6 August 2023₹155
5 August 2023₹199
4 August 2023₹188
3 August 2023₹185
2 August 2023₹185
1 August 2023₹180

Concord Biotech IPO Detail Video:


Concord Biotech IPO Subscription Status (Bidding Detail)

The Concord Biotech IPO on August 8, 2023 at 7:30:00 PM was subscribed 24.87 times, with the retail category being subscribed 3.78 times, the NII (Non-Institutional Investor) category being subscribed 16.99 times, the QIB (Qualified-Institutional Buyers) category being subscribed 67.67 times and the Employee category being subscribed 24.48 times.


Concord Biotech IPO Prospectus

Concord Biotech IPO DRHPDownload
Concord Biotech IPO RHPDownload
Concord Biotech IPO Anchor Investors Details PDFDownload

Concord Biotech IPO Rating

Our Rating2.5/5.0

Concord Biotech Company Contact Information

Concord Biotech Limited

Registered Office: 1482-86, Trasad Road, Dholka, Ahmedabad
– 382225, Gujarat, India
Corporate Office: 16th floor, B-Wing, Mondeal Heights, Iscon Cross Road,
S.G. Highway, Ahmedabad – 380015, Gujarat, India;
Contact Person: Prakash Sajnani, Company Secretary and Compliance Officer, and Assistant Vice President (Finance)
Telephone: 079-6813 8700
Corporate Identity Number: U24230GJ1984PLC007440

Concord Biotech IPO Registrar

Link Intime India Private Limited

Address: C 101, 247 Park L.B.S Marg Vikhroli (West),
Mumbai 400 083 Maharashtra, India
Tel: +91 810 811 4949
Investor Grievance ID:
Contact Person: Shanti Gopalkrishnan
SEBI Registration Number: INR000004058

Concord Biotech IPO Lead Manager

Kotak Mahindra Capital Company Limited

Address: 1st Floor, 27 BKC, Plot No. 27 G Block, Bandra Kurla Complex
Bandra (East), Mumbai 400 051, Maharashtra, India
Tel: +91 22 4336 0000
Investor Grievance ID:
Contact Person: Ganesh Rane
SEBI Registration Number: INM000008704

Citigroup Global Markets India Private Limited

Address: 1202, 12th Floor, First International Financial Centre,
G Block Bandra Kurla Complex, Bandra (East), Mumbai 400 098
Maharashtra, India
Tel: +91 22 6175 9999
Investor Grievance ID:
Contact Person: Karan Singh Hundal
SEBI Registration Number: INM000010718

Jefferies India Private Limited

Address: Level 16, Express Towers Nariman Point,
Mumbai 400021 Maharashtra, India
Tel: +91 22 4356 6000
Investor Grievance ID:
Contact Person: Suhani Bhareja
SEBI Registration Number: INM000011443

Concord Biotech IPO FAQs

What is the lot size of Concord Biotech IPO?

The total size of Concord Biotech IPO is 1551 crores and this is a complete offer for sale (OFS) Issue.

When will Concord Biotech IPO start?

Concord Biotech IPO will open from 4 August 2023 and IPO will close on 8 August 2023.

What is the open date of Concord Biotech IPO?

Concord Biotech IPO will open date from 4 August 2023.

What is the last date ( close date ) of Concord Biotech IPO?

Concord Biotech IPO will close from 8 August 2023.

What is the price band of Concord Biotech IPO?

Concord Biotech IPO price band is ₹705 to ₹741. ( Upper Price Band: ₹741, Lower Price Band: ₹705 )

What is the minimum amount required to apply for Concord Biotech IPO?

The minimum investment for retailers to apply for Concord Biotech IPO is ₹14,820 and the maximum investment is ₹192,660.

What is going on gray market premium of Concord Biotech IPO?

View gray market premium of Concord Biotech IPO by Clicking Here

How much is the GMP of Concord Biotech IPO?

Watch Concord Biotech IPO GMP Today: Click Here

What is the allotment date of Concord Biotech IPO?

The allotment date of Concord Biotech IPO is 11 August 2023.

How to check allotment status in Concord Biotech IPO?

To check the allotment status of Concord Biotech IPO, first of all go to the registrar website by clicking here, select your bad Concord Biotech IPO name or enter your bad application number, PAN number or client ID and click on submit. ( Video Link )

What is the listing date of Concord Biotech IPO?

The listing date of Concord Biotech IPO is 18 August 2023.

How much will be the listing gain in Concord Biotech IPO?

View listing gain of Concord Biotech IPO by Clicking Here

How much time Concord Biotech IPO is subscribed?

Total 24.87 times subscribed in Concord Biotech IPO out of which 3.78 times subscription was done in retail quota, 16.99 times subscription in NII quota, 67.67 times subscription in QIB quota and the Employee category being subscribed 24.48 times.

How to apply for Concord Biotech IPO from Upstox?

Click Here to see how to apply for Concord Biotech IPO from Upstox. (step by step)

How to apply for Concord Biotech IPO from Zerodha?

Click Here to see how to apply for Concord Biotech IPO from Zerodha. (step by step)

How to apply for Concord Biotech IPO from Angle One?

Click Here to see how to apply for Concord Biotech IPO from Angle One. (step by step)

Leave a Reply

Your email address will not be published. Required fields are marked *